Developing CorneaClear, an engineered corneal implant meant to replace donor corneal tissue. The company says a synthetic, room temperature stable implant avoids the rejection risk and immunosuppressant use that follow a donor transplant.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
No Spam. Unsubscribe anytime.